Cargando…
Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
Autoimmune hepatitis (AIH) is characterized by a progressive destruction of the liver parenchyma and a chronic fibrosis. The current treatment of autoimmune hepatitis is still largely dependent on the administration of corticosteroids and cytostatic drugs. For a long time the development of novel th...
Autores principales: | Christen, Urs, Hintermann, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187807/ https://www.ncbi.nlm.nih.gov/pubmed/27916939 http://dx.doi.org/10.3390/ijms17122007 |
Ejemplares similares
-
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
por: Hintermann, Edith, et al.
Publicado: (2012) -
Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?
por: Christen, Urs, et al.
Publicado: (2022) -
Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
por: Christen, Urs, et al.
Publicado: (2018) -
Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013) -
N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)